SCHEMBL8443076

SCHEMBL8443076

CC(=NOCCO)c1ccc(-c2ccncc2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
PTBP1 P26599 1/20 0.42
MAPK1 P28482 1/20 0.41
HTT P42858 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
CYP3A4 P08684 6/20 0.39
CYP2D6 P10635 1/20 0.39
CYP17A1 P05093 6/20 0.38
CYP19A1 P11511 6/20 0.38
CYP11B1 P15538 6/20 0.38
CYP11B2 P19099 6/20 0.38
HDAC1 Q13547 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
PPARA Q07869 4/20 0.36
S1PR1 P21453 3/20 0.36
PPARG P37231 3/20 0.35
PRKACA P17612 1/20 0.35
CDK8 P49336 1/20 0.35
GSK3A P49840 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8442117 0.84 MKNK1 (0.48) LMNASMN1; SMN2PTBP1MAPK1HTT
SCHEMBL8309933 0.84 PPARA (0.48) LMNASMN1; SMN2PTBP1MAPK1HTT
SCHEMBL8309932 0.84 PPARA (0.48) LMNASMN1; SMN2PTBP1MAPK1HTT
SCHEMBL5610798 0.84 LMNA (0.56) LMNASMN1; SMN2PTBP1MAPK1HTT
SCHEMBL5610797 0.84 LMNA (0.56) LMNASMN1; SMN2PTBP1MAPK1HTT
SCHEMBL5609892 0.83 LMNA (0.65) LMNASMN1; SMN2PTBP1MAPK1HTT
SCHEMBL5609899 0.83 LMNA (0.65) LMNASMN1; SMN2PTBP1MAPK1HTT
SCHEMBL8304869 0.82 PPARG (0.52) LMNASMN1; SMN2PTBP1MAPK1HTT
SCHEMBL8304871 0.82 PPARG (0.52) LMNASMN1; SMN2PTBP1MAPK1HTT
SCHEMBL5609817 0.81 PPARG (0.50) LMNASMN1; SMN2PTBP1MAPK1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5972959-A Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY, LIMITED (JP) 1999-10-26 US disclosed
EP-0708098-B1 Oxime derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1999-03-03 EP disclosed
EP-0708098-A1 Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1996-04-24 EP disclosed